1. Home
  2. AII vs CRVS Comparison

AII vs CRVS Comparison

Compare AII & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AII
  • CRVS
  • Stock Information
  • Founded
  • AII 2006
  • CRVS 2014
  • Country
  • AII United States
  • CRVS United States
  • Employees
  • AII N/A
  • CRVS N/A
  • Industry
  • AII Property-Casualty Insurers
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AII Finance
  • CRVS Health Care
  • Exchange
  • AII Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • AII 370.5M
  • CRVS 305.4M
  • IPO Year
  • AII 2025
  • CRVS 2016
  • Fundamental
  • Price
  • AII $19.46
  • CRVS $5.50
  • Analyst Decision
  • AII Buy
  • CRVS Strong Buy
  • Analyst Count
  • AII 4
  • CRVS 4
  • Target Price
  • AII $21.67
  • CRVS $15.00
  • AVG Volume (30 Days)
  • AII 72.3K
  • CRVS 499.6K
  • Earning Date
  • AII 08-12-2025
  • CRVS 08-07-2025
  • Dividend Yield
  • AII N/A
  • CRVS N/A
  • EPS Growth
  • AII N/A
  • CRVS N/A
  • EPS
  • AII 60.71
  • CRVS N/A
  • Revenue
  • AII $260,047,000.00
  • CRVS N/A
  • Revenue This Year
  • AII $25.16
  • CRVS N/A
  • Revenue Next Year
  • AII $34.05
  • CRVS N/A
  • P/E Ratio
  • AII $0.32
  • CRVS N/A
  • Revenue Growth
  • AII 1.73
  • CRVS N/A
  • 52 Week Low
  • AII $15.78
  • CRVS $2.54
  • 52 Week High
  • AII $19.88
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • AII N/A
  • CRVS 66.45
  • Support Level
  • AII N/A
  • CRVS $5.03
  • Resistance Level
  • AII N/A
  • CRVS $5.64
  • Average True Range (ATR)
  • AII 0.00
  • CRVS 0.32
  • MACD
  • AII 0.00
  • CRVS 0.06
  • Stochastic Oscillator
  • AII 0.00
  • CRVS 81.36

About AII American Integrity Insurance Group Inc. Common Stock

American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: